{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:59:04Z","timestamp":1790362744149,"version":"4.1.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11225-1","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:52:48Z","timestamp":1790315568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Animal-Derived Antimicrobial Peptides: Emerging Therapeutic Strategies against Multidrug-Resistant Pathogens"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0489-4857","authenticated-orcid":false,"given":"Mallu","family":"Mallikarjuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1760-3321","authenticated-orcid":false,"given":"Narasimha","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"10459","key":"11225_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS et al (2024) Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404(10459):1199\u20131226","journal-title":"Lancet"},{"issue":"9","key":"11225_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","volume":"25","author":"H Sati","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, WHO Bacterial Priority Pathogens List Advisory Group et al (2025) The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis 25(9):1033\u20131043","journal-title":"Lancet Infect Dis"},{"issue":"10325","key":"11225_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629\u2013655","journal-title":"Lancet"},{"issue":"10","key":"11225_CR4","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/pathogens10101310","volume":"10","author":"G Mancuso","year":"2021","unstructured":"Mancuso G, Midiri A, Gerace E, Biondo C (2021) Bacterial antibiotic resistance: the most critical pathogens. Pathogens 10(10):1310","journal-title":"Pathogens"},{"issue":"12","key":"11225_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"REW Hancock","year":"2006","unstructured":"Hancock REW, Sahl HG (2006) Antimicrobial and host-defence peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551\u20131557","journal-title":"Nat Biotechnol"},{"issue":"5","key":"11225_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","volume":"19","author":"N Mookherjee","year":"2020","unstructured":"Mookherjee N, Anderson MA, Haagsman HP, Davidson DJ (2020) Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov 19(5):311\u2013332","journal-title":"Nat Rev Drug Discov"},{"issue":"6870","key":"11225_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(6870):389\u2013395","journal-title":"Nature"},{"issue":"3","key":"11225_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238\u2013250","journal-title":"Nat Rev Microbiol"},{"issue":"D1","key":"11225_CR9","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","volume":"44","author":"G Wang","year":"2016","unstructured":"Wang G, Li X, Wang Z (2016) APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res 44(D1):D1087\u2013D1093","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"11225_CR10","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/S1473-3099(20)30327-3","volume":"20","author":"M Magana","year":"2020","unstructured":"Magana M, Pushpanathan M, Santos AL et al (2020) The value of antimicrobial peptides in the age of resistance. Lancet Infect Dis 20(9):e216\u2013e230","journal-title":"Lancet Infect Dis"},{"issue":"6490","key":"11225_CR11","doi-asserted-by":"publisher","first-page":"eaau5480","DOI":"10.1126\/science.aau5480","volume":"368","author":"BP Lazzaro","year":"2020","unstructured":"Lazzaro BP, Zasloff M, Rolff J (2020) Antimicrobial peptides: application informed by evolution. Science 368(6490):eaau5480","journal-title":"Science"},{"issue":"9","key":"11225_CR12","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1021\/acsinfecdis.4c00314","volume":"10","author":"R Samat","year":"2024","unstructured":"Samat R, Sen S, Jash M, Ghosh S, Garg S, Sarkar J, Ghosh S (2024) Venom: a promising avenue for antimicrobial therapeutics. ACS Infect Dis 10(9):3098\u20133125","journal-title":"ACS Infect Dis"},{"issue":"8","key":"11225_CR13","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1021\/acsinfecdis.6c00118","volume":"12","author":"J Ghosh","year":"2026","unstructured":"Ghosh J, Deb S, Jana M, Mukherjee S, Singh P, Dey K, Maity S, Pal S, Sen S (2026) Antimicrobial peptides and biofilms: from molecular interactions to therapeutic control. ACS Infect Dis 12(8):2416\u20132437","journal-title":"ACS Infect Dis"},{"issue":"7","key":"11225_CR14","first-page":"3919","volume":"11","author":"J Lei","year":"2019","unstructured":"Lei J, Sun L, Huang S et al (2019) The antimicrobial peptides and their potential clinical applications. Am J Transl Res 11(7):3919\u20133931","journal-title":"Am J Transl Res"},{"key":"11225_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev.iy.13.040195.000425","volume":"13","author":"HG Boman","year":"1995","unstructured":"Boman HG (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13:61\u201392","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"11225_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M","volume":"55","author":"A Tossi","year":"2000","unstructured":"Tossi A, Sandri L, Giangaspero A (2000) Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55(1):4\u201330","journal-title":"Biopolymers"},{"issue":"19","key":"11225_CR17","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1021\/acs.jpcb.4c01249","volume":"128","author":"MS Sheridan","year":"2024","unstructured":"Sheridan MS, Pandey P, Hansmann UHE (2024) In bacterial membranes lipid II changes the stability of pores formed by the antimicrobial peptide nisin. J Phys Chem B 128(19):4741\u20134750","journal-title":"J Phys Chem B"},{"issue":"9","key":"11225_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nri1180","volume":"3","author":"T Ganz","year":"2003","unstructured":"Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3(9):710\u2013720","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"11225_CR19","first-page":"2470","volume":"10","author":"F Bauer","year":"2001","unstructured":"Bauer F, Schweimer K, Kluver E et al (2001) Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci 10(12):2470\u20132479","journal-title":"Protein Sci"},{"issue":"11","key":"11225_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00018-005-5540-2","volume":"63","author":"M Pazgier","year":"2006","unstructured":"Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J (2006) Human beta-defensins. Cell Mol Life Sci 63(11):1294\u20131313","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"11225_CR21","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1007\/s11033-012-1997-x","volume":"39","author":"EM Kosciuczuk","year":"2012","unstructured":"Kosciuczuk EM, Lisowski P, Jarczak J et al (2012) Cathelicidins: family of antimicrobial peptides. A review. Mol Biol Rep 39(12):10957\u201310970","journal-title":"Mol Biol Rep"},{"issue":"1","key":"11225_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"CD Fjell","year":"2012","unstructured":"Fjell CD, Hiss JA, Hancock REW, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11(1):37\u201351","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"11225_CR23","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/ph6121543","volume":"6","author":"AA Bahar","year":"2013","unstructured":"Bahar AA, Ren D (2013) Antimicrobial peptides. Pharmaceuticals 6(12):1543\u20131575","journal-title":"Pharmaceuticals"},{"issue":"6","key":"11225_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ni1206","volume":"6","author":"ME Selsted","year":"2005","unstructured":"Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6(6):551\u2013557","journal-title":"Nat Immunol"},{"issue":"1","key":"11225_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0952-7915(01)00303-X","volume":"14","author":"RI Lehrer","year":"2002","unstructured":"Lehrer RI, Ganz T (2002) Defensins of vertebrate animals. Curr Opin Immunol 14(1):96\u2013102","journal-title":"Curr Opin Immunol"},{"key":"11225_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fimmu.2020.00764","volume":"11","author":"D Xu","year":"2020","unstructured":"Xu D, Lu W (2020) Defensins: a double-edged sword in host immunity. Front Immunol 11:764","journal-title":"Front Immunol"},{"issue":"5439","key":"11225_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.286.5439.498","volume":"286","author":"YQ Tang","year":"1999","unstructured":"Tang YQ, Yuan J, Osapay G et al (1999) A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 286(5439):498\u2013502","journal-title":"Science"},{"issue":"5","key":"11225_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2174\/1389203043379459","volume":"5","author":"ME Selsted","year":"2004","unstructured":"Selsted ME (2004) Theta-Defensins: cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins. Curr Protein Pept Sci 5(5):365\u2013371","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"11225_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1189\/jlb.0403147","volume":"75","author":"M Zanetti","year":"2004","unstructured":"Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75(1):39\u201348","journal-title":"J Leukoc Biol"},{"issue":"1","key":"11225_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00011-025-02005-8","volume":"74","author":"D Svensson","year":"2025","unstructured":"Svensson D, Nilsson BO (2025) Human antimicrobial\/host defense peptide LL-37 may prevent the spread of a local infection through multiple mechanisms: an update. Inflamm Res 74(1):24","journal-title":"Inflamm Res"},{"issue":"9","key":"11225_CR31","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1128\/IAI.00318-08","volume":"76","author":"J Overhage","year":"2008","unstructured":"Overhage J, Campisano A, Bains M, Torfs ECW, Rehm BHA, Hancock REW (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76(9):4176\u20134182","journal-title":"Infect Immun"},{"issue":"8","key":"11225_CR32","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1517\/13543784.9.8.1731","volume":"9","author":"L Bellm","year":"2000","unstructured":"Bellm L, Lehrer RI, Ganz T (2000) Protegrins: new antibiotics of mammalian origin. Expert Opin Investig Drugs 9(8):1731\u20131742","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"11225_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0166-3542(01)00146-2","volume":"51","author":"JH Andersen","year":"2001","unstructured":"Andersen JH, Osbakk SA, Vorland LH, Traavik T, Gutteberg TJ (2001) Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 51(2):141\u2013149","journal-title":"Antiviral Res"},{"key":"11225_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.peptides.2014.04.019","volume":"57","author":"JM Conlon","year":"2014","unstructured":"Conlon JM, Mechkarska M, Lukic ML, Flatt PR (2014) Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides 57:67\u201377","journal-title":"Peptides"},{"issue":"15","key":"11225_CR35","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","volume":"84","author":"M Zasloff","year":"1987","unstructured":"Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84(15):5449\u20135453","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"11225_CR36","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.2174\/0929867325666180713125314","volume":"26","author":"J Patocka","year":"2019","unstructured":"Patocka J, Nepovimova E, Klimova B, Wu Q, Kuca K (2019) Antimicrobial peptides: amphibian host defense peptides. Curr Med Chem 26(32):5924\u20135946","journal-title":"Curr Med Chem"},{"issue":"9","key":"11225_CR37","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s00018-005-5536-y","volume":"63","author":"ML Mangoni","year":"2006","unstructured":"Mangoni ML (2006) Temporins, anti-infective peptides with expanding properties. Cell Mol Life Sci 63(9):1060\u20131069","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"11225_CR38","doi-asserted-by":"publisher","first-page":"e0128663","DOI":"10.1371\/journal.pone.0128663","volume":"10","author":"A Di Grazia","year":"2015","unstructured":"Di Grazia A, Cappiello F, Imanishi A et al (2015) The frog skin-derived antimicrobial peptide esculentin-1a(1\u201321)NH2 promotes the migration of human HaCaT keratinocytes in an EGF receptor-dependent manner. PLoS ONE 10(6):e0128663","journal-title":"PLoS ONE"},{"issue":"12","key":"11225_CR39","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1086\/593185","volume":"47","author":"BA Lipsky","year":"2008","unstructured":"Lipsky BA, Holroyd KJ, Zasloff M (2008) Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 47(12):1537\u20131545","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11225_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/ph7030265","volume":"7","author":"JA Masso-Silva","year":"2014","unstructured":"Masso-Silva JA, Diamond G (2014) Antimicrobial peptides from fish. Pharmaceuticals 7(3):265\u2013310","journal-title":"Pharmaceuticals"},{"key":"11225_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10989-020-10068-w","volume":"27","author":"SV Raju","year":"2021","unstructured":"Raju SV, Sarkar P, Kumar P, Arockiaraj J (2021) Piscidin, fish antimicrobial peptide: structure, classification, properties, mechanism, gene regulation and therapeutical importance. Int J Pept Res Ther 27:91\u2013107","journal-title":"Int J Pept Res Ther"},{"issue":"18","key":"11225_CR42","doi-asserted-by":"publisher","first-page":"12008","DOI":"10.1074\/jbc.272.18.12008","volume":"272","author":"AM Cole","year":"1997","unstructured":"Cole AM, Weis P, Diamond G (1997) Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J Biol Chem 272(18):12008\u201312013","journal-title":"J Biol Chem"},{"issue":"4","key":"11225_CR43","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.fsi.2012.09.021","volume":"34","author":"A Tassanakajon","year":"2013","unstructured":"Tassanakajon A, Somboonwiwat K, Supungul P, Tang S (2013) Discovery of immune molecules and their crucial functions in shrimp immunity. Fish Shellfish Immunol 34(4):954\u2013967","journal-title":"Fish Shellfish Immunol"},{"issue":"8\u20139","key":"11225_CR44","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/PL00000764","volume":"57","author":"D Destoumieux","year":"2000","unstructured":"Destoumieux D, Munoz M, Bulet P, Bachere E (2000) Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda). Cell Mol Life Sci 57(8\u20139):1260\u20131271","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"11225_CR45","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.dci.2007.12.002","volume":"32","author":"VJ Smith","year":"2008","unstructured":"Smith VJ, Fernandes JMO, Kemp GD, Hauton C (2008) Crustins: enigmatic WAP domain-containing antibacterial proteins from crustaceans. Dev Comp Immunol 32(7):758\u2013772","journal-title":"Dev Comp Immunol"},{"issue":"10","key":"11225_CR46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/md16100381","volume":"16","author":"GM Matos","year":"2018","unstructured":"Matos GM, Schmitt P, Barreto C et al (2018) Massive gene expansion and sequence diversification is associated with diverse tissue distribution, regulation and antimicrobial properties of anti-lipopolysaccharide factors in shrimp. Mar Drugs 16(10):381","journal-title":"Mar Drugs"},{"key":"11225_CR47","doi-asserted-by":"publisher","first-page":"1732053","DOI":"10.3389\/fmicb.2025.1732053","volume":"16","author":"C Hu","year":"2025","unstructured":"Hu C, Chen F, Zhou Y et al (2025) Scymicrosin7-26, a Scylla paramamosain-derived novel antimicrobial peptide, exhibits efficacy against multidrug-resistant ESKAPE pathogens and anti-inflammatory activity. Front Microbiol 16:1732053","journal-title":"Front Microbiol"},{"key":"11225_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev.mi.41.100187.000535","volume":"41","author":"HG Boman","year":"1987","unstructured":"Boman HG, Hultmark D (1987) Cell-free immunity in insects. Annu Rev Microbiol 41:103\u2013126","journal-title":"Annu Rev Microbiol"},{"issue":"13","key":"11225_CR49","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1007\/s00253-014-5792-6","volume":"98","author":"HY Yi","year":"2014","unstructured":"Yi HY, Chowdhury M, Huang YD, Yu XQ (2014) Insect antimicrobial peptides and their applications. Appl Microbiol Biotechnol 98(13):5807\u20135822","journal-title":"Appl Microbiol Biotechnol"},{"issue":"23","key":"11225_CR50","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.3390\/ijms20235862","volume":"20","author":"D Brady","year":"2019","unstructured":"Brady D, Grapputo A, Romoli O, Sandrelli F (2019) Insect cecropins, antimicrobial peptides with potential therapeutic applications. Int J Mol Sci 20(23):5862","journal-title":"Int J Mol Sci"},{"issue":"11","key":"11225_CR51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/toxins10110461","volume":"10","author":"Q Wu","year":"2018","unstructured":"Wu Q, Patocka J, Kuca K (2018) Insect antimicrobial peptides, a mini review. Toxins 10(11):461","journal-title":"Toxins"},{"issue":"2","key":"11225_CR52","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/antibiotics10020212","volume":"10","author":"F Buonocore","year":"2021","unstructured":"Buonocore F, Fausto AM, Della Pelle G, Roncevic T, Gerdol M, Picchietti S (2021) Attacins: a promising class of insect antimicrobial peptides. Antibiotics 10(2):212","journal-title":"Antibiotics"},{"issue":"1","key":"11225_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/cimb48010062","volume":"48","author":"RX Yuan","year":"2026","unstructured":"Yuan RX, Ma XY, Lv Y, Si HB (2026) Molecular diversity, structure-function relationship, mechanism of action, and transformative potential of black soldier fly antimicrobial peptides against multidrug-resistant pathogens. Curr Issues Mol Biol 48(1):62","journal-title":"Curr Issues Mol Biol"},{"issue":"43","key":"11225_CR54","doi-asserted-by":"publisher","first-page":"33464","DOI":"10.1074\/jbc.M001491200","volume":"275","author":"PI Silva Jr","year":"2000","unstructured":"Silva PI Jr, Daffre S, Bulet P (2000) Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J Biol Chem 275(43):33464\u201333470","journal-title":"J Biol Chem"},{"issue":"12","key":"11225_CR55","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s00018-003-3106-8","volume":"60","author":"L Kuhn-Nentwig","year":"2003","unstructured":"Kuhn-Nentwig L (2003) Antimicrobial and cytolytic peptides of venomous arthropods. Cell Mol Life Sci 60(12):2651\u20132668","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"11225_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/jms.577","volume":"39","author":"BA Budnik","year":"2004","unstructured":"Budnik BA, Olsen JV, Egorov TA et al (2004) De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis. J Mass Spectrom 39(2):193\u2013201","journal-title":"J Mass Spectrom"},{"key":"11225_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13071-016-1360-5","volume":"9","author":"N Miyoshi","year":"2016","unstructured":"Miyoshi N, Saito T, Ohmura T, Kuroda K, Suita K, Ihara K, Isogai E (2016) Functional structure and antimicrobial activity of persulcatusin, an antimicrobial peptide from the hard tick Ixodes persulcatus. Parasit Vectors 9:85","journal-title":"Parasit Vectors"},{"key":"11225_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.toxicon.2014.06.006","volume":"88","author":"PL Harrison","year":"2014","unstructured":"Harrison PL, Abdel-Rahman MA, Miller K, Strong PN (2014) Antimicrobial peptides from scorpion venoms. Toxicon 88:115\u2013137","journal-title":"Toxicon"},{"issue":"4","key":"11225_CR59","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/toxins15040268","volume":"15","author":"WG Lima","year":"2023","unstructured":"Lima WG, de Lima ME (2023) Therapeutic prospection of animal venoms-derived antimicrobial peptides against infections by multidrug-resistant Acinetobacter baumannii: a systematic review of pre-clinical studies. Toxins 15(4):268","journal-title":"Toxins"},{"key":"11225_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.peptides.2013.10.021","volume":"51","author":"A Almaaytah","year":"2014","unstructured":"Almaaytah A, Albalas Q (2014) Scorpion venom peptides with no disulfide bridges: a review. Peptides 51:35\u201345","journal-title":"Peptides"},{"issue":"2\u20133","key":"11225_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0014-5793(00)01384-3","volume":"471","author":"R Conde","year":"2000","unstructured":"Conde R, Zamudio FZ, Rodriguez MH, Possani LD (2000) Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett 471(2\u20133):165\u2013168","journal-title":"FEBS Lett"},{"issue":"Pt 1","key":"11225_CR62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1042\/bj3590035","volume":"359","author":"G Corzo","year":"2001","unstructured":"Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T (2001) Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem J 359(Pt 1):35\u201345","journal-title":"Biochem J"},{"issue":"16","key":"11225_CR63","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1046\/j.1432-1327.2000.01556.x","volume":"267","author":"A Torres-Larios","year":"2000","unstructured":"Torres-Larios A, Gurrola GB, Zamudio FZ, Possani LD (2000) Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur J Biochem 267(16):5023\u20135031","journal-title":"Eur J Biochem"},{"issue":"8","key":"11225_CR64","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00253-019-09698-y","volume":"103","author":"H Memariani","year":"2019","unstructured":"Memariani H, Memariani M, Shahidi-Dadras M, Nasiri S, Akhavan MM, Moravvej H (2019) Melittin: from honeybees to superbugs. Appl Microbiol Biotechnol 103(8):3265\u20133276","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"11225_CR65","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.3892\/mmr.2015.4275","volume":"12","author":"JH Choi","year":"2015","unstructured":"Choi JH, Jang AY, Lin S et al (2015) Melittin, a honeybee venom-derived antimicrobial peptide, may target methicillin-resistant Staphylococcus aureus. Mol Med Rep 12(5):6483\u20136490","journal-title":"Mol Med Rep"},{"issue":"11","key":"11225_CR66","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.3390\/nu12113360","volume":"12","author":"M Carpena","year":"2020","unstructured":"Carpena M, Nunez-Estevez B, Soria-Lopez A, Simal-Gandara J (2020) Bee venom: an updating review of its bioactive molecules and its health applications. Nutrients 12(11):3360","journal-title":"Nutrients"},{"key":"11225_CR67","first-page":"108890","volume":"239","author":"JR Almeida","year":"2021","unstructured":"Almeida JR, Mendes B, Patino RSP et al (2021) Snake venoms: a new source of antimicrobial peptides. Comp Biochem Physiol C Toxicol Pharmacol 239:108890","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"11","key":"11225_CR68","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00726-014-1801-4","volume":"46","author":"CB Falcao","year":"2014","unstructured":"Falcao CB, de La Torre BG, Perez-Peinado C et al (2014) Vipericidins: a novel family of cathelicidin-related peptides from the venom gland of South American pit vipers. Amino Acids 46(11):2561\u20132571","journal-title":"Amino Acids"},{"key":"11225_CR69","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3389\/fphar.2019.01415","volume":"10","author":"E de Barros","year":"2019","unstructured":"de Barros E, Goncalves RM, Cardoso MH, Santos NC, Franco OL, Candido ES (2019) Snake venom cathelicidins as natural antimicrobial peptides. Front Pharmacol 10:1415","journal-title":"Front Pharmacol"},{"issue":"9","key":"11225_CR70","doi-asserted-by":"publisher","first-page":"e3217","DOI":"10.1371\/journal.pone.0003217","volume":"3","author":"Y Wang","year":"2008","unstructured":"Wang Y, Hong J, Liu X et al (2008) Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS ONE 3(9):e3217","journal-title":"PLoS ONE"},{"issue":"7","key":"11225_CR71","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s12272-013-0248-6","volume":"37","author":"J Wang","year":"2014","unstructured":"Wang J, Li B, Li Y et al (2014) BF-30 effectively inhibits ciprofloxacin-resistant bacteria in vitro and in a rat model of vaginosis. Arch Pharm Res 37(7):927\u2013936","journal-title":"Arch Pharm Res"},{"issue":"16","key":"11225_CR72","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1021\/acs.jmedchem.3c01150","volume":"66","author":"S Sen","year":"2023","unstructured":"Sen S, Samat R, Jash M, Ghosh S, Roy R, Mukherjee N, Ghosh S, Sarkar J, Ghosh S (2023) Potential broad-spectrum antimicrobial, wound healing, and disinfectant cationic peptide crafted from snake venom. J Med Chem 66(16):11555\u201311572","journal-title":"J Med Chem"},{"issue":"4","key":"11225_CR73","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/toxins12040255","volume":"12","author":"C Perez-Peinado","year":"2020","unstructured":"Perez-Peinado C, Defaus S, Andreu D (2020) Hitchhiking with nature: snake venom peptides to fight cancer and superbugs. Toxins 12(4):255","journal-title":"Toxins"},{"issue":"2","key":"11225_CR74","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11696-019-00939-y","volume":"74","author":"A Bocian","year":"2020","unstructured":"Bocian A, Hus KK (2020) Antibacterial properties of snake venom components. Chem Pap 74(2):407\u2013419","journal-title":"Chem Pap"},{"issue":"3","key":"11225_CR75","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/sj.jid.5700599","volume":"127","author":"F Niyonsaba","year":"2007","unstructured":"Niyonsaba F, Ushio H, Nakano N et al (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127(3):594\u2013604","journal-title":"J Invest Dermatol"},{"issue":"4","key":"11225_CR76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/14787210.2018.1441024","volume":"16","author":"I Martin-Loeches","year":"2018","unstructured":"Martin-Loeches I, Dale GE, Torres A (2018) Murepavadin: a new antibiotic class in the pipeline. Expert Rev Anti Infect Ther 16(4):259\u2013268","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"11225_CR77","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/157489106777452638","volume":"1","author":"MN Melo","year":"2006","unstructured":"Melo MN, Dugourd D, Castanho MARB (2006) Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides. Recent Pat Antiinfect Drug Discov 1(2):201\u2013207","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"1","key":"11225_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1124\/pr.55.1.2","volume":"55","author":"MR Yeaman","year":"2003","unstructured":"Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55(1):27\u201355","journal-title":"Pharmacol Rev"},{"issue":"9","key":"11225_CR79","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","volume":"8","author":"REW Hancock","year":"2000","unstructured":"Hancock REW, Diamond G (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8(9):402\u2013410","journal-title":"Trends Microbiol"},{"issue":"10","key":"11225_CR80","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/cb1001558","volume":"5","author":"WC Wimley","year":"2010","unstructured":"Wimley WC (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5(10):905\u2013917","journal-title":"ACS Chem Biol"},{"issue":"6","key":"11225_CR81","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1021\/acs.accounts.6b00074","volume":"49","author":"MA Sani","year":"2016","unstructured":"Sani MA, Separovic F (2016) How membrane-active peptides get into lipid membranes. Acc Chem Res 49(6):1130\u20131138","journal-title":"Acc Chem Res"},{"issue":"1\u20132","key":"11225_CR82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00232-011-9343-0","volume":"239","author":"WC Wimley","year":"2011","unstructured":"Wimley WC, Hristova K (2011) Antimicrobial peptides: successes, challenges and unanswered questions. J Membr Biol 239(1\u20132):27\u201334","journal-title":"J Membr Biol"},{"issue":"4","key":"11225_CR83","doi-asserted-by":"publisher","first-page":"e02340","DOI":"10.1128\/AAC.02340-16","volume":"61","author":"CF Le","year":"2017","unstructured":"Le CF, Fang CM, Sekaran SD (2017) Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother 61(4):e02340\u2013e02316","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"11225_CR84","doi-asserted-by":"publisher","first-page":"E1409","DOI":"10.1073\/pnas.1319900111","volume":"111","author":"M Wenzel","year":"2014","unstructured":"Wenzel M, Chiriac AI, Otto A et al (2014) Small cationic antimicrobial peptides delocalize peripheral membrane proteins. Proc Natl Acad Sci USA 111(14):E1409\u2013E1418","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"11225_CR85","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1016\/j.jmb.2018.12.015","volume":"431","author":"MDT Torres","year":"2019","unstructured":"Torres MDT, Sothiselvam S, Lu TK, de la Fuente-Nunez C (2019) Peptide design principles for antimicrobial applications. J Mol Biol 431(18):3547\u20133567","journal-title":"J Mol Biol"},{"issue":"5","key":"11225_CR86","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1128\/AAC.45.5.1367-1373.2001","volume":"45","author":"DM Rothstein","year":"2001","unstructured":"Rothstein DM, Spacciapoli P, Tran LT et al (2001) Anticandidal activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob Agents Chemother 45(5):1367\u20131373","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"11225_CR87","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri.2016.29","volume":"16","author":"REW Hancock","year":"2016","unstructured":"Hancock REW, Haney EF, Gill EE (2016) The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol 16(5):321\u2013334","journal-title":"Nat Rev Immunol"},{"key":"11225_CR88","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.immunol.22.012703.104603","volume":"22","author":"D Yang","year":"2004","unstructured":"Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ (2004) Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22:181\u2013215","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"11225_CR89","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","volume":"192","author":"Q De Yang, Chen","year":"2000","unstructured":"De Yang, Chen Q, Schmidt AP et al (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192(7):1069\u20131074","journal-title":"J Exp Med"},{"issue":"5","key":"11225_CR90","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1039\/B813787K","volume":"5","author":"N Mookherjee","year":"2009","unstructured":"Mookherjee N, Hamill P, Gardy J et al (2009) Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells. Mol Biosyst 5(5):483\u2013496","journal-title":"Mol Biosyst"},{"issue":"9","key":"11225_CR91","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.it.2014.07.004","volume":"35","author":"SC Mansour","year":"2014","unstructured":"Mansour SC, Pena OM, Hancock REW (2014) Host defense peptides: front-line immunomodulators. Trends Immunol 35(9):443\u2013450","journal-title":"Trends Immunol"},{"issue":"20","key":"11225_CR92","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.3390\/ijms222011172","volume":"22","author":"M Drayton","year":"2021","unstructured":"Drayton M, Deisinger JP, Ludwig KC, Raheem N, Muller A, Schneider T, Straus SK (2021) Host defense peptides: dual antimicrobial and immunomodulatory action. Int J Mol Sci 22(20):11172","journal-title":"Int J Mol Sci"},{"issue":"19","key":"11225_CR93","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1128\/JB.00017-16","volume":"198","author":"D Pletzer","year":"2016","unstructured":"Pletzer D, Hancock REW (2016) Antibiofilm peptides: potential as broad-spectrum agents. J Bacteriol 198(19):2572\u20132578","journal-title":"J Bacteriol"},{"issue":"5","key":"11225_CR94","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.bbamem.2015.10.013","volume":"1858","author":"G Batoni","year":"2016","unstructured":"Batoni G, Maisetta G, Esin S (2016) Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta 1858(5):1044\u20131060","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"11225_CR95","doi-asserted-by":"publisher","first-page":"e1004152","DOI":"10.1371\/journal.ppat.1004152","volume":"10","author":"C de la Fuente-Nunez","year":"2014","unstructured":"de la Fuente-Nunez C, Reffuveille F, Haney EF, Straus SK, Hancock REW (2014) Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog 10(5):e1004152","journal-title":"PLoS Pathog"},{"key":"11225_CR96","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3389\/fmicb.2017.02409","volume":"8","author":"L Grassi","year":"2017","unstructured":"Grassi L, Maisetta G, Esin S, Batoni G (2017) Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms. Front Microbiol 8:2409","journal-title":"Front Microbiol"},{"issue":"6","key":"11225_CR97","doi-asserted-by":"publisher","first-page":"488","DOI":"10.24272\/j.issn.2095-8137.2019.062","volume":"40","author":"J Mwangi","year":"2019","unstructured":"Mwangi J, Hao X, Lai R, Zhang ZY (2019) Antimicrobial peptides: new hope in the war against multidrug resistance. Zool Res 40(6):488\u2013505","journal-title":"Zool Res"},{"issue":"52","key":"11225_CR98","doi-asserted-by":"publisher","first-page":"26516","DOI":"10.1073\/pnas.1909585117","volume":"116","author":"J Mwangi","year":"2019","unstructured":"Mwangi J, Yin Y, Wang G et al (2019) The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection. Proc Natl Acad Sci USA 116(52):26516\u201326522","journal-title":"Proc Natl Acad Sci USA"},{"key":"11225_CR99","doi-asserted-by":"publisher","first-page":"1390765","DOI":"10.3389\/fmicb.2024.1390765","volume":"15","author":"A Cesaro","year":"2024","unstructured":"Cesaro A, Della Pelle G, Dell\u2019Olmo E et al (2024) Synergistic action of antimicrobial peptides and antibiotics: current understanding and future directions. Front Microbiol 15:1390765","journal-title":"Front Microbiol"},{"issue":"3","key":"11225_CR100","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1128\/AAC.02434-15","volume":"60","author":"G Yu","year":"2016","unstructured":"Yu G, Baeder DY, Regoes RR, Rolff J (2016) Combination effects of antimicrobial peptides. Antimicrob Agents Chemother 60(3):1717\u20131724","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"11225_CR101","doi-asserted-by":"publisher","first-page":"e00311","DOI":"10.1128\/AAC.00311-18","volume":"62","author":"HS Sader","year":"2018","unstructured":"Sader HS, Dale GE, Rhomberg PR, Flamm RK (2018) Antimicrobial activity of murepavadin tested against clinical isolates of Pseudomonas aeruginosa from the United States, Europe, and China. Antimicrob Agents Chemother 62(7):e00311\u2013e00318","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"11225_CR102","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/jac\/dkaa529","volume":"76","author":"M Diez-Aguilar","year":"2021","unstructured":"Diez-Aguilar M, Hernandez-Garcia M, Morosini MI et al (2021) Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates. J Antimicrob Chemother 76(4):984\u2013992","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"11225_CR103","doi-asserted-by":"publisher","first-page":"e00410","DOI":"10.1128\/mSphere.00410-17","volume":"2","author":"G Sakoulas","year":"2017","unstructured":"Sakoulas G, Kumaraswamy M, Kousha A, Nizet V (2017) Interaction of antibiotics with innate host defense factors against Salmonella enterica serotype Newport. mSphere 2(6):e00410\u2013e00417","journal-title":"mSphere"},{"key":"11225_CR104","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drup.2016.04.002","volume":"26","author":"DI Andersson","year":"2016","unstructured":"Andersson DI, Hughes D, Kubicek-Sutherland JZ (2016) Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist Updat 26:43\u201357","journal-title":"Drug Resist Updat"},{"issue":"1695","key":"11225_CR105","doi-asserted-by":"publisher","first-page":"20150292","DOI":"10.1098\/rstb.2015.0292","volume":"371","author":"HS Joo","year":"2016","unstructured":"Joo HS, Fu CI, Otto M (2016) Bacterial strategies of resistance to antimicrobial peptides. Philos Trans R Soc Lond B Biol Sci 371(1695):20150292","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"11225_CR106","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/antibiotics4010018","volume":"4","author":"VI Band","year":"2015","unstructured":"Band VI, Weiss DS (2015) Mechanisms of antimicrobial peptide resistance in Gram-negative bacteria. Antibiotics 4(1):18\u201341","journal-title":"Antibiotics"},{"issue":"6","key":"11225_CR107","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1046\/j.1365-2958.1998.00757.x","volume":"27","author":"JS Gunn","year":"1998","unstructured":"Gunn JS, Lim KB, Krueger J, Kim K, Guo L, Hackett M, Miller SI (1998) PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 27(6):1171\u20131182","journal-title":"Mol Microbiol"},{"issue":"13","key":"11225_CR108","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.1074\/jbc.274.13.8405","volume":"274","author":"A Peschel","year":"1999","unstructured":"Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274(13):8405\u20138410","journal-title":"J Biol Chem"},{"key":"11225_CR109","doi-asserted-by":"publisher","first-page":"593215","DOI":"10.3389\/fmicb.2020.593215","volume":"11","author":"L Assoni","year":"2020","unstructured":"Assoni L, Milani B, Carvalho MR et al (2020) Resistance mechanisms to antimicrobial peptides in Gram-positive bacteria. Front Microbiol 11:593215","journal-title":"Front Microbiol"},{"issue":"9","key":"11225_CR110","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.193.9.1067","volume":"193","author":"A Peschel","year":"2001","unstructured":"Peschel A, Jack RW, Otto M et al (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J Exp Med 193(9):1067\u20131076","journal-title":"J Exp Med"},{"issue":"15","key":"11225_CR111","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1128\/JB.180.15.4002-4006.1998","volume":"180","author":"S Stumpe","year":"1998","unstructured":"Stumpe S, Schmid R, Stephens DL, Georgiou G, Bakker EP (1998) Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J Bacteriol 180(15):4002\u20134006","journal-title":"J Bacteriol"},{"issue":"12","key":"11225_CR112","doi-asserted-by":"publisher","first-page":"7107","DOI":"10.1128\/IAI.72.12.7107-7114.2004","volume":"72","author":"MA Campos","year":"2004","unstructured":"Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72(12):7107\u20137114","journal-title":"Infect Immun"},{"issue":"2","key":"11225_CR113","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.4049\/jimmunol.172.2.1169","volume":"172","author":"T Jin","year":"2004","unstructured":"Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A (2004) Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172(2):1169\u20131176","journal-title":"J Immunol"},{"issue":"2","key":"11225_CR114","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu YY, Wang Y, Walsh TR et al (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16(2):161\u2013168","journal-title":"Lancet Infect Dis"},{"key":"11225_CR115","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","volume":"5","author":"AO Olaitan","year":"2014","unstructured":"Olaitan AO, Morand S, Rolain JM (2014) Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643","journal-title":"Front Microbiol"},{"key":"11225_CR116","doi-asserted-by":"publisher","first-page":"616979","DOI":"10.3389\/fmicb.2021.616979","volume":"12","author":"GS Dijksteel","year":"2021","unstructured":"Dijksteel GS, Ulrich MMW, Middelkoop E, Boekema BKHL (2021) Lessons learned from clinical trials using antimicrobial peptides (AMPs). Front Microbiol 12:616979","journal-title":"Front Microbiol"},{"issue":"5","key":"11225_CR117","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.coph.2006.04.006","volume":"6","author":"AK Marr","year":"2006","unstructured":"Marr AK, Gooderham WJ, Hancock REW (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6(5):468\u2013472","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"11225_CR118","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/AAC.00477-08","volume":"53","author":"AA Stromstedt","year":"2009","unstructured":"Stromstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M (2009) Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother 53(2):593\u2013602","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"11225_CR119","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/antibiotics9010024","volume":"9","author":"CH Chen","year":"2020","unstructured":"Chen CH, Lu TK (2020) Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics 9(1):24","journal-title":"Antibiotics"},{"issue":"19","key":"11225_CR120","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.3390\/ijms21197047","volume":"21","author":"K Browne","year":"2020","unstructured":"Browne K, Chakraborty S, Chen R et al (2020) A new era of antibiotics: the clinical potential of antimicrobial peptides. Int J Mol Sci 21(19):7047","journal-title":"Int J Mol Sci"},{"key":"11225_CR121","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-981-13-3588-4_15","volume":"1117","author":"F Costa","year":"2019","unstructured":"Costa F, Teixeira C, Gomes P, Martins MCL (2019) Clinical application of AMPs. Adv Exp Med Biol 1117:281\u2013298","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"11225_CR122","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/S1473-3099(20)30327-3","volume":"20","author":"M Magana","year":"2020","unstructured":"Magana M, Pushpanathan M, Santos AL et al (2020) The value of antimicrobial peptides in the age of resistance. Lancet Infect Dis 20(9):e216\u2013e230","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"11225_CR123","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/ph8030366","volume":"8","author":"B Mojsoska","year":"2015","unstructured":"Mojsoska B, Jenssen H (2015) Peptides and peptidomimetics for antimicrobial drug design. Pharmaceuticals 8(3):366\u2013415","journal-title":"Pharmaceuticals"},{"issue":"11","key":"11225_CR124","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0006-2952(99)00259-2","volume":"58","author":"SY Hong","year":"1999","unstructured":"Hong SY, Oh JE, Lee KH (1999) Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem Pharmacol 58(11):1775\u20131780","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"11225_CR125","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1348-0421.2002.tb02759.x","volume":"46","author":"K Hamamoto","year":"2002","unstructured":"Hamamoto K, Kida Y, Zhang Y, Shimizu T, Kuwano K (2002) Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol Immunol 46(11):741\u2013749","journal-title":"Microbiol Immunol"},{"issue":"3","key":"11225_CR126","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0360-3016(03)01627-4","volume":"58","author":"A Trotti","year":"2004","unstructured":"Trotti A, Garden A, Warde P et al (2004) A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys 58(3):674\u2013681","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"11225_CR127","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/wrr.12211","volume":"22","author":"A Gronberg","year":"2014","unstructured":"Gronberg A, Mahlapuu M, Stahle M, Whately-Smith C, Rollman O (2014) Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial. Wound Repair Regen 22(5):613\u2013621","journal-title":"Wound Repair Regen"},{"issue":"7061","key":"11225_CR128","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature04051","volume":"437","author":"PH Mygind","year":"2005","unstructured":"Mygind PH, Fischer RL, Schnorr KM et al (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437(7061):975\u2013980","journal-title":"Nature"},{"issue":"3","key":"11225_CR129","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/nano10030560","volume":"10","author":"MC Teixeira","year":"2020","unstructured":"Teixeira MC, Carbone C, Sousa MC et al (2020) Nanomedicines for the delivery of antimicrobial peptides (AMPs). Nanomaterials 10(3):560","journal-title":"Nanomaterials"},{"key":"11225_CR130","doi-asserted-by":"publisher","first-page":"114733","DOI":"10.1016\/j.addr.2023.114733","volume":"196","author":"A Cesaro","year":"2023","unstructured":"Cesaro A, Lin S, Pardi N, de la Fuente-Nunez C (2023) Advanced delivery systems for peptide antibiotics. Adv Drug Deliv Rev 196:114733","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"11225_CR131","doi-asserted-by":"publisher","first-page":"18040","DOI":"10.3390\/ijms151018040","volume":"15","author":"AM Carmona-Ribeiro","year":"2014","unstructured":"Carmona-Ribeiro AM, Carrasco LD (2014) Novel formulations for antimicrobial peptides. Int J Mol Sci 15(10):18040\u201318083","journal-title":"Int J Mol Sci"},{"key":"11225_CR132","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biomaterials.2016.01.051","volume":"85","author":"A Rai","year":"2016","unstructured":"Rai A, Pinto S, Velho TR et al (2016) One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model. Biomaterials 85:99\u2013110","journal-title":"Biomaterials"},{"issue":"24","key":"11225_CR133","doi-asserted-by":"publisher","first-page":"13212","DOI":"10.3390\/ijms222413212","volume":"22","author":"MG Drexelius","year":"2021","unstructured":"Drexelius MG, Neundorf I (2021) Application of antimicrobial peptides on biomedical implants: three ways to pursue peptide coatings. Int J Mol Sci 22(24):13212","journal-title":"Int J Mol Sci"},{"key":"11225_CR134","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3389\/fmicb.2019.03097","volume":"10","author":"MH Cardoso","year":"2020","unstructured":"Cardoso MH, Orozco RQ, Rezende SB et al (2020) Computer-aided design of antimicrobial peptides: are we generating effective drug candidates? Front Microbiol 10:3097","journal-title":"Front Microbiol"},{"issue":"D1","key":"11225_CR135","doi-asserted-by":"publisher","first-page":"D288","DOI":"10.1093\/nar\/gkaa991","volume":"49","author":"M Pirtskhalava","year":"2021","unstructured":"Pirtskhalava M, Gabrielian A, Cruz P et al (2021) DBAASP v3: database of antimicrobial\/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Res 49(D1):D288\u2013D297","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"11225_CR136","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pro.3702","volume":"29","author":"G Wang","year":"2020","unstructured":"Wang G (2020) The antimicrobial peptide database provides a platform for decoding the design principles of naturally occurring antimicrobial peptides. Protein Sci 29(1):8\u201318","journal-title":"Protein Sci"},{"issue":"7","key":"11225_CR137","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1021\/acs.jcim.1c00175","volume":"61","author":"PGA Aronica","year":"2021","unstructured":"Aronica PGA, Reid LM, Desai N et al (2021) Computational methods and tools in antimicrobial peptide research. J Chem Inf Model 61(7):3172\u20133196","journal-title":"J Chem Inf Model"},{"issue":"10","key":"11225_CR138","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/antibiotics11101451","volume":"11","author":"J Yan","year":"2022","unstructured":"Yan J, Cai J, Zhang B, Wang Y, Wong DF, Siu SWI (2022) Recent progress in the discovery and design of antimicrobial peptides using traditional machine learning and deep learning. Antibiotics 11(10):1451","journal-title":"Antibiotics"},{"issue":"6","key":"11225_CR139","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41551-021-00689-x","volume":"5","author":"P Das","year":"2021","unstructured":"Das P, Sercu T, Wadhawan K et al (2021) Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat Biomed Eng 5(6):613\u2013623","journal-title":"Nat Biomed Eng"},{"issue":"7","key":"11225_CR140","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41551-024-01201-x","volume":"8","author":"F Wan","year":"2024","unstructured":"Wan F, Torres MDT, Peng J, de la Fuente-Nunez C (2024) Deep-learning-enabled antibiotic discovery through molecular de-extinction. Nat Biomed Eng 8(7):854\u2013871","journal-title":"Nat Biomed Eng"},{"issue":"8","key":"11225_CR141","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.chom.2023.07.001","volume":"31","author":"JRMA Maasch","year":"2023","unstructured":"Maasch JRMA, Torres MDT, Melo MCR, de la Fuente-Nunez C (2023) Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning. Cell Host Microbe 31(8):1260\u20131274e6","journal-title":"Cell Host Microbe"},{"issue":"26","key":"11225_CR142","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.1039\/D1SC01713F","volume":"12","author":"A Capecchi","year":"2021","unstructured":"Capecchi A, Cai X, Personne H, Kohler T, van Delden C, Reymond JL (2021) Machine learning designs non-hemolytic antimicrobial peptides. Chem Sci 12(26):9221\u20139232","journal-title":"Chem Sci"},{"issue":"5","key":"11225_CR143","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2174\/1568026616666160713143331","volume":"17","author":"KE Greber","year":"2017","unstructured":"Greber KE, Dawgul M (2017) Antimicrobial peptides under clinical trials. Curr Top Med Chem 17(5):620\u2013628","journal-title":"Curr Top Med Chem"},{"key":"11225_CR144","unstructured":"ClinicalTrials.gov NCT01447017 A study of DPK-060 to investigate clinical safety and efficacy in patients with acute external otitis. DermaGen AB; completed, phase 2"},{"key":"11225_CR145","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3389\/fmicb.2019.01689","volume":"10","author":"M Vaara","year":"2019","unstructured":"Vaara M (2019) Polymyxins and their potential next generation as therapeutic antibiotics. Front Microbiol 10:1689","journal-title":"Front Microbiol"},{"issue":"1","key":"11225_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.70.1.1","volume":"70","author":"RJ Dubos","year":"1939","unstructured":"Dubos RJ (1939) Studies on a bactericidal agent extracted from a soil bacillus: I. Preparation of the agent, its activity in vitro. J Exp Med 70(1):1\u201310","journal-title":"J Exp Med"},{"issue":"6","key":"11225_CR147","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.0.CO;2-8","volume":"47","author":"M Simmaco","year":"1998","unstructured":"Simmaco M, Mignogna G, Barra D (1998) Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47(6):435\u2013450","journal-title":"Biopolymers"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11225-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:02:05Z","timestamp":1790359325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11225-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":147,"alternative-id":["11225"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11225-1","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have used Paperpal and ChatGPT for language editing and grammar improvement during the preparation of this manuscript. The illustrative figures (Figures 1, 2, 4, and 5) are original schematic diagrams produced by the authors to represent the mechanisms and data described in the cited literature; they are not reproductions or adaptations of any previously published figure, and no permissions were therefore required. After the use of AI-assisted language tools, the author(s) thoroughly reviewed, verified, and revised all AI-assisted content, and independently re-verified every citation and clinical claim against its primary source during this revision, to ensure accuracy and originality. The author(s) take full responsibility for the integrity and final content of the published article.","order":2,"name":"Ethics","label":"Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}